XTX Topco Ltd Makes New $251,000 Investment in Nutex Health Inc. (NASDAQ:NUTX)

XTX Topco Ltd purchased a new position in shares of Nutex Health Inc. (NASDAQ:NUTX - Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm purchased 7,905 shares of the company's stock, valued at approximately $251,000. XTX Topco Ltd owned 0.15% of Nutex Health as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Drive Wealth Management LLC acquired a new stake in shares of Nutex Health during the fourth quarter valued at about $1,122,000. Legato Capital Management LLC boosted its holdings in shares of Nutex Health by 26.8% in the 4th quarter. Legato Capital Management LLC now owns 31,669 shares of the company's stock valued at $1,004,000 after buying an additional 6,697 shares during the period. Russell Investments Group Ltd. bought a new stake in shares of Nutex Health in the 4th quarter worth approximately $672,000. Baader Bank Aktiengesellschaft bought a new stake in shares of Nutex Health during the fourth quarter valued at approximately $206,000. Finally, American Century Companies Inc. acquired a new stake in Nutex Health in the fourth quarter worth about $1,362,000. Institutional investors and hedge funds own 5.32% of the company's stock.

Nutex Health Stock Up 4.1 %

Shares of NUTX stock traded up $4.54 on Thursday, hitting $114.51. The company's stock had a trading volume of 40,122 shares, compared to its average volume of 58,949. Nutex Health Inc. has a fifty-two week low of $4.16 and a fifty-two week high of $152.51. The firm's fifty day moving average price is $81.56 and its 200-day moving average price is $51.95. The company has a debt-to-equity ratio of 3.36, a current ratio of 1.77 and a quick ratio of 1.74. The stock has a market capitalization of $632.98 million, a price-to-earnings ratio of -12.24 and a beta of 0.27.

Nutex Health (NASDAQ:NUTX - Get Free Report) last posted its earnings results on Monday, March 31st. The company reported $11.12 earnings per share for the quarter, topping the consensus estimate of ($0.09) by $11.21. Nutex Health had a negative return on equity of 51.27% and a negative net margin of 14.09%. The firm had revenue of $81.30 million during the quarter, compared to analyst estimates of $81.13 million.

Analysts Set New Price Targets

Separately, Maxim Group lifted their price target on Nutex Health from $75.00 to $100.00 and gave the company a "buy" rating in a report on Tuesday, April 8th.

Insider Activity at Nutex Health

In other Nutex Health news, CFO Jon Christian Bates acquired 1,000 shares of Nutex Health stock in a transaction dated Tuesday, April 8th. The stock was bought at an average cost of $81.81 per share, with a total value of $81,810.00. Following the completion of the transaction, the chief financial officer now owns 4,888 shares of the company's stock, valued at $399,887.28. The trade was a 25.72 % increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. 38.52% of the stock is currently owned by company insiders.

Nutex Health Profile

Nutex Health Inc operates as a physician-led, healthcare services, and operations company. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The PHM segment establishes and operates independent physician associations; and offers a cloud-based platform for healthcare organizations to provide value-based care and population health management.